The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly (Prelude)

AstraZeneca

Status: Completed

Conditions: Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT01370577

NIS-RKR-XXX-2011/1

Details and patient eligibility

About

The Predictors for asthma control by stepwise treatment during 6 months in Korean elderly

Enrollment: 297 patients

Sex: All

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged 60 years or more, articulate in Korean
• Patients diagnosed with asthma, at least 1 year in duration.

Exclusion criteria

• Patients being followed-up for asthma treatment less than 1 year before baseline
• Patients taking immune therapy
• Patients previously enrolled/randomized in the present clinical trial

Trial design

297 participants in 1 patient group

1

Description:

Total 300 subjects who was diagnosed with asthma